These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38705489)

  • 1. Application of Recombinant Human Superoxide Dismutase in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Acute Rectal Injury: A Multicenter, Randomized, Open-label, Prospective Trial.
    Zhu J; Li X; Huang M; Zhu H; Tan Y; He X; Sun Z; Cheng H; Li F; Jiang P; Lou H; Ke G; Cao X; Zhu L; Xie P; Yan J; Zhang F
    Int J Radiat Oncol Biol Phys; 2024 Nov; 120(3):720-729. PubMed ID: 38705489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy: results of a multicenter randomized placebo-controlled dose-finding phase 2 study.
    Maggio A; Magli A; Rancati T; Fiorino C; Valvo F; Fellin G; Ricardi U; Munoz F; Cosentino D; Cazzaniga LF; Valdagni R; Vavassori V
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):518-24. PubMed ID: 24803033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic radiation-induced rectal injury after adjuvant radiotherapy for pelvic malignant tumors: report based on a phase 3 randomized clinical trial].
    Zhou Y; Huang H; Wan T; Feng YL; Liu JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):962-968. PubMed ID: 34823296
    [No Abstract]   [Full Text] [Related]  

  • 4. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE).
    Wang CJ; Leung SW; Chen HC; Sun LM; Fang FM; Huang EY; Hsiung CY; Changchien CC
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):85-91. PubMed ID: 9422562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315.
    Zachariah B; Gwede CK; James J; Ajani J; Chin LJ; Donath D; Rosenthal SA; Kane BL; Rotman M; Berk L; Kachnic LA
    J Natl Cancer Inst; 2010 Apr; 102(8):547-56. PubMed ID: 20339140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects.
    Dale PS; Tamhankar CP; George D; Daftary GV
    Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S29-34. PubMed ID: 11561869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome.
    Rosenfeld WN; Davis JM; Parton L; Richter SE; Price A; Flaster E; Kassem N
    Pediatrics; 1996 Jun; 97(6 Pt 1):811-7. PubMed ID: 8657519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 2 Randomized Controlled Trial of Radiation Therapy Plus Concurrent Interferon-Alpha and Retinoic Acid Versus Cisplatin for Stage III Cervical Carcinoma.
    Basu P; Jenson AB; Majhi T; Choudhury P; Mandal R; Banerjee D; Biswas J; Pan J; Rai SN; Ghim SJ; Miller D
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):102-110. PubMed ID: 26700705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative Hypofractionated Intensity-Modulated Radiotherapy With Concurrent Chemotherapy in Cervical Cancer: The POHIM-CCRT Nonrandomized Controlled Trial.
    Cho WK; Park W; Kim SW; Lee KK; Ahn KJ; Choi JH
    JAMA Oncol; 2024 Jun; 10(6):737-743. PubMed ID: 38662364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of free radical-mediated reperfusion injury on acute and chronic rejection events following cadaveric renal transplantation.
    Schneeberger H; Schleibner S; Illner WD; Messmer K; Land W
    Clin Transpl; 1993; ():219-32. PubMed ID: 7918155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase.
    Parad RB; Allred EN; Rosenfeld WN; Davis JM
    Neonatology; 2012; 102(2):139-44. PubMed ID: 22710821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB-IVA cervical cancer: study protocol for a randomized controlled trial.
    Li J; Liu H; Li Y; Li J; Shen L; Long W; Yang C; Xu H; Xi W; Cai R; Feng W
    Trials; 2022 Jan; 23(1):29. PubMed ID: 35012634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients.
    Chitapanarux I; Chitapanarux T; Traisathit P; Kudumpee S; Tharavichitkul E; Lorvidhaya V
    Radiat Oncol; 2010 May; 5():31. PubMed ID: 20444243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer.
    Zou D; Guo M; Zhou Q
    BMC Cancer; 2021 Jun; 21(1):661. PubMed ID: 34078317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rectal enemas on rectal dosimetric parameters during high-dose-rate vaginal cuff brachytherapy: A prospective trial.
    Sabater S; Andrés I; Gascon M; Rovirosa A; Sevillano M; Berenguer R; Camacho-Lopez C; Aguayo M; Villas MV; Arenas M
    Strahlenther Onkol; 2016 Apr; 192(4):248-53. PubMed ID: 26803316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiation therapy (IMRT)-based concurrent chemoradiotherapy (CCRT) with Endostar in patients with pelvic locoregional recurrence of cervical cancer: Results from a hospital in the Qinghai-Tibet Plateau.
    Zhang K; Wang H; Wang Z; Li F; Cui Y; Ma S; Chen R; Wang Y; Guo S; Wei Y
    Medicine (Baltimore); 2020 Dec; 99(49):e21966. PubMed ID: 33285664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II multicenter randomized study of amifostine for prevention of acute radiation rectal toxicity: topical intrarectal versus subcutaneous application.
    Kouloulias VE; Kouvaris JR; Pissakas G; Mallas E; Antypas C; Kokakis JD; Matsopoulos G; Michopoulos S; Mystakidou K; Vlahos LJ
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):486-93. PubMed ID: 15890591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegylated recombinant human granulocyte colony-stimulating factor for primary prophylaxis of neutropenia in patients with cervical cancer receiving concurrent chemoradiotherapy: a prospective study.
    You J; Yuan Y; Gu X; Wang W; Li X
    BMC Cancer; 2024 Jul; 24(1):833. PubMed ID: 38997665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric modulated arc therapy.
    Cheng YK; Kuo SH; Yen HH; Wu JH; Chen YC; Huang MY
    Radiat Oncol; 2022 May; 17(1):91. PubMed ID: 35549962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.